Role of tumor-associated neutrophils in lung cancer (Review)
Copyright: © Zhou et al..
Lung cancer is the most common malignancy and the leading cause of cancer mortality worldwide; therefore, it is very important to understand the mechanism of its occurrence and progression. It has reported that inflammation is linked to the incidence of various malignancies. Neutrophils not only participate in the inflammatory response, but are also involved in the composition of the tumor microenvironment. Tumor-associated neutrophils (TANs) are infiltrating neutrophils in tumors that directly promote tumor development and progression. Moreover, they regulate the immune microenvironment and affect the therapeutic efficacy and prognosis of lung cancer. In the present review, the role of TANs in lung cancer development/progression and the underlying molecular signaling are evaluated, as well as the possibility of TANs as a potential therapeutic target for lung cancer intervention.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
---|---|
Enthalten in: |
Oncology letters - 25(2023), 1 vom: 17. Jan., Seite 2 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhou, Jinhua [VerfasserIn] |
---|
Links: |
---|
Themen: |
CXCR |
---|
Anmerkungen: |
Date Revised 25.11.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3892/ol.2022.13588 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM349328439 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM349328439 | ||
003 | DE-627 | ||
005 | 20231226042344.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3892/ol.2022.13588 |2 doi | |
028 | 5 | 2 | |a pubmed24n1164.xml |
035 | |a (DE-627)NLM349328439 | ||
035 | |a (NLM)36419755 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhou, Jinhua |e verfasserin |4 aut | |
245 | 1 | 0 | |a Role of tumor-associated neutrophils in lung cancer (Review) |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 25.11.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright: © Zhou et al. | ||
520 | |a Lung cancer is the most common malignancy and the leading cause of cancer mortality worldwide; therefore, it is very important to understand the mechanism of its occurrence and progression. It has reported that inflammation is linked to the incidence of various malignancies. Neutrophils not only participate in the inflammatory response, but are also involved in the composition of the tumor microenvironment. Tumor-associated neutrophils (TANs) are infiltrating neutrophils in tumors that directly promote tumor development and progression. Moreover, they regulate the immune microenvironment and affect the therapeutic efficacy and prognosis of lung cancer. In the present review, the role of TANs in lung cancer development/progression and the underlying molecular signaling are evaluated, as well as the possibility of TANs as a potential therapeutic target for lung cancer intervention | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a CXCR | |
650 | 4 | |a immunity | |
650 | 4 | |a lung cancer | |
650 | 4 | |a neutrophils | |
650 | 4 | |a tumor microenvironment | |
700 | 1 | |a Liu, Huan |e verfasserin |4 aut | |
700 | 1 | |a Jiang, Shulong |e verfasserin |4 aut | |
700 | 1 | |a Wang, Wei |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Oncology letters |d 2010 |g 25(2023), 1 vom: 17. Jan., Seite 2 |w (DE-627)NLM201171317 |x 1792-1082 |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:2023 |g number:1 |g day:17 |g month:01 |g pages:2 |
856 | 4 | 0 | |u http://dx.doi.org/10.3892/ol.2022.13588 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 25 |j 2023 |e 1 |b 17 |c 01 |h 2 |